These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 18385667)

  • 21. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.
    Murgia S; Quattrocchio G; Forneris G; Pozzato M; Fenoglio R; Ferro M; De Simone E; Del Vecchio G; Di Benedetto C; Roccatello D
    J Nephrol; 2022 May; 35(4):1243-1249. PubMed ID: 34982413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy.
    Mehta S; Shtaynberg N; Goldman M; Asti D; Kiroycheva M; Pepe J
    Hematology; 2012 Jul; 17(4):229-31. PubMed ID: 22889516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal failure in multiple myeloma and its treatment].
    Ryšavá R
    Vnitr Lek; 2020; 66(7):425-431. PubMed ID: 33380121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid reduction of extremely high kappa free light chains in a patient with myeloma cast nephropathy.
    Snozek CLH; Kinard TN; Adamski J
    J Clin Apher; 2018 Jun; 33(3):439-443. PubMed ID: 29427353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
    Hutchison CA; Heyne N; Airia P; Schindler R; Zickler D; Cook M; Cockwell P; Grima D
    Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Renal failure in multiple myeloma: Specific management issues].
    Try M; Harel S
    Bull Cancer; 2024; 111(7-8):733-740. PubMed ID: 36759215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
    Cockwell P; Cook M
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):324-32. PubMed ID: 22920643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study.
    Lin ZS; Qin AB; Wang SX; Yu XJ; Dong B; Xiong ZY; Chen MH; Zhou FD; Zhao MH
    J Nephrol; 2021 Aug; 34(4):1169-1177. PubMed ID: 33394345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of acute kidney injury in symptomatic multiple myeloma.
    Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP;
    Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report.
    Donati G; Zappulo F; Croci Chiocchini AL; Comai G; Zamagni E; La Manna G
    Hemodial Int; 2019 Jul; 23(3):E97-E99. PubMed ID: 30791209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence of myeloma cast nephropathy, light chain deposition disease, and nonamyloid fibrils in a patient with multiple myeloma.
    Qian Q; Leung N; Theis JD; Dogan A; Sethi S
    Am J Kidney Dis; 2010 Nov; 56(5):971-6. PubMed ID: 20870327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Morphological and immunochemical features of nephropathies in multiple myeloma and severe renal failure].
    Rechtina IG; Golitsina EP; Varlamova EIu; Varshvskiĭ VA; Kireeva AA; Biriukova LS; Savchenko VG
    Ter Arkh; 2013; 85(3):80-5. PubMed ID: 23720848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
    Herrera GA
    Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012.
    Tan J; Lam-Po-Tang M; Hutchison CA; de Zoysa JR
    Nephrology (Carlton); 2014 Jul; 19(7):432-5. PubMed ID: 24931113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dialysis-dependent renal failure in patients with multiple myeloma: Reversibility factors].
    Rekhtina IG; Mendeleeva LP; Biryukova LS
    Ter Arkh; 2015; 87(7):72-76. PubMed ID: 26390728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloma light chain cast nephropathy, a review.
    Sathick IJ; Drosou ME; Leung N
    J Nephrol; 2019 Apr; 32(2):189-198. PubMed ID: 29730782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.
    Granger Vallée A; Chenine L; Leray-Moragues H; Patrier L; Cognot C; Cartron G; Cristol JP; Canaud B
    Nephrol Dial Transplant; 2011 Nov; 26(11):3627-33. PubMed ID: 21508098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.
    Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S
    J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of primary renal allograft dysfunction due to myeloma cast nephropathy.
    Lingaraj U; Vankalakunti M; Radhakrishnan H; Sreedhara CG; Rajanna S
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):970-5. PubMed ID: 26354571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.